Cellbyte supports local and global Pricing & Market Access teams in the successful launch of new medicines. The AI-based platform lets users analyze cross-country regulatory data, HTA assessments, and pricing information within seconds, or extract targeted insights from more than 30,000 specialist documents. We also develop specialized AI agents that, using curated data, execute recurring workflows - such as dossier preparation, endpoint validation, or price validation - quickly, precisely, and transparently.
The serial entrepreneurs Daniel Moreira, Felix Steinbrenner, and Samuel Moreira bring many years of experience at the intersection of AI and life sciences. They have previously worked at renowned companies and consultancies such as Simon-Kucher, Celonis, and Y Combinator.